# Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor

> **NCT06456359** · PHASE2 · RECRUITING · sponsor: **University Hospital Heidelberg** · enrollment: 28 (estimated)

## Conditions studied

- Desmoplastic Small Round Cell Tumor
- Synovial Sarcoma

## Interventions

- **DRUG:** Signifor

## Key facts

- **NCT ID:** NCT06456359
- **Lead sponsor:** University Hospital Heidelberg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-19
- **Primary completion:** 2027-10
- **Final completion:** 2028-10
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06456359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06456359, "Pasireotide as Maintenance Treatment in Synovial Sarcoma and Desmoplastic Small Round Cell Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06456359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*